ROSETTA INPHARMATICS LLC

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 2123
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205
 
 
 
G06F ELECTRIC DIGITAL DATA PROCESSING 1446

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
7569343 Methods to assess quality of microarraysJun 27, 03Aug 04, 09[C12Q]
7171311 Methods of assigning treatment to breast cancer patientsJan 15, 03Jan 30, 07[G01N]
7150969 Alternatively spliced isoform of acetyl-CoA carboxylase 2 (ACC2)Jun 03, 05Dec 19, 06[C12Q]
7035739 Computer systems and methods for identifying genes and determining pathways associated with traitsFeb 03, 03Apr 25, 06[G06F]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2012/0072,124 GENES ASSOCIATED WITH PROGRESSION AND RESPONSE IN CHRONIC MYELOID LEUKEMIA AND USES THEREOFAbandonedAug 10, 11Mar 22, 12[G01N, G06F]
8014957 Genes associated with progression and response in chronic myeloid leukemia and uses thereofExpiredDec 14, 06Sep 06, 11[G01N]
2011/0166,028 METHODS FOR PREDICTING TREATMENT RESPONSE BASED ON THE EXPRESSION PROFILES OF BIOMARKER GENES IN NOTCH MEDIATED CANCERSAbandonedAug 22, 08Jul 07, 11[C12Q, G01N, C40B]
7966130 Systems and methods for determining a weighted mean intensityExpiredNov 04, 02Jun 21, 11[G01N, G06F]
2010/0113,287 METHODS FOR ASSESSING THE REPRESENTATION OF NUCLEIC ACID MOLECULES IN A NUCLEIC ACID LIBRARYAbandonedSep 21, 09May 06, 10[C40B]
2010/0040,552 METHODS TO EVALUATE GLUCOCORTICOID RECEPTOR AGONISTS AND ANTAGONISTS FOR EFFECTS ON NEURON-LIKE CELLSAbandonedOct 14, 09Feb 18, 10[A61K, G01N, A61P]
2010/0029,511 CDNA SYNTHESIS USING NON-RANDOM PRIMERSAbandonedJul 24, 09Feb 04, 10[C12P, C40B]
2009/0192,135 Human Niemann Pick C1-Like 1 Gene (NPC1L1) Polymorphisms and Methods of Use ThereofAbandonedMar 28, 06Jul 30, 09[A61K, C07H, C12Q, C40B]
7565251 Systems and methods for evaluating the significance of differences in biological measurementsExpiredDec 12, 05Jul 21, 09[G01N]
2009/0136,957 Methods and compositions for regulating cell cycle progression via the miR-106B familyAbandonedSep 15, 08May 28, 09[C12Q, C12N]
2009/0004,645 Methods for Identifying Genes that Mediate a Response of a Living Cell to an AgentAbandonedApr 12, 05Jan 01, 09[C12Q]
2008/0102,475 Alternatively spliced isoform of phosphodiesterase 4B (PDE4B)AbandonedOct 10, 07May 01, 08[C07H, C12N, G01N, C07K]
7254487 Methods for determining therapeutic index from gene expression profilesExpiredApr 02, 01Aug 07, 07[G01N]
2007/0134,660 Methods for identifying modulators of kinesin activityAbandonedMay 28, 04Jun 14, 07[A61K, C12Q, G01N]
2007/0092,913 Methods for identifying agents that modulate GPR105 activityAbandonedOct 19, 06Apr 26, 07[C07H, C12P, G01N, C07K]
2007/0081,222 Adjustable pinhole for a laser-scanning microscopeAbandonedMay 12, 04Apr 12, 07[G02B]
2007/0006,917 Dye-sensitized solar cellAbandonedOct 04, 04Jan 11, 07[H01L]
2006/0292,623 Signature genes in chronic myelogenous leukemiaAbandonedAug 25, 06Dec 28, 06[C12Q, G06F]
2006/0281,117 Alternatively spliced isoform of calcium channel, voltage dependent, alpha-1G subunit (CACNA1G)AbandonedMay 26, 06Dec 14, 06[C07H, C12Q, C12P, G01N, C07K]
7130746 Computer systems and computer programs for determining protein activity levels using gene expression profilesExpiredOct 12, 01Oct 31, 06[G01N]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.